October 2, 2023- As part of the Cleveland Innovation District, Cleveland Clinic has opened the first phase of its expanded research facilities and announced plans to launch major construction of two new research buildings. The state-of-the-art facilities will be dedicated to scientific investigation and will significantly increase laboratory research space on Cleveland Clinic’s main campus.
The Cleveland Innovation District, a unique public-private initiative, brings the State of Ohio and JobsOhio together with Cleveland’s healthcare and higher education institutions to create jobs, accelerate research and educate the workforce of the future.
Opening this month is 45,000 square feet of remodeled space to house leading-edge laboratories. Several of Cleveland Clinic’s fastest-growing research programs have moved to the space including the Center for Computational Life Sciences, Center for Immunotherapy and Precision Immuno-oncology that includes the Cell Therapy Program, and vaccine development. It also includes the Center for Therapeutics Discovery, which features floor-to-ceiling glass walls, providing a “science on display” feature with a view of scientists at work.
Cleveland Clinic is also opening a new biosafety level 3 laboratory for sophisticated pathogen research. The biosafety lab will enable researchers to expand their work to investigate infectious pathogens. The facility operates under stringent biosafety protocols set by the Centers for Disease Control and provides an important resource for scientists to safely develop diagnostics, treatments and vaccines to prevent and treat infectious diseases.